What is Arcus Biosciences's change in AP?

Arcus Biosciences (RCUS) reported change in AP of -$3M in Q1 2026.

How has Arcus Biosciences's change in AP changed year-over-year?

Arcus Biosciences's change in AP decreased by 200.0% year-over-year, from $3M to -$3M.

What is the long-term trend for Arcus Biosciences's change in AP?

Over 3 years (2021 to 2025), Arcus Biosciences's change in AP has grown at a 64.2% compound annual growth rate (CAGR), from -$5.42M to $24M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Arcus Biosciences RCUS Change in AP

Change in AP at other companies

Bristol-Myers SquibbBMY

$409M+581%

Merck & Co.MRK

$27.5M-39.6%

Regeneron PharmaceuticalsREGN

$107.7M+150%

AbbVieABBV

-$1.59B-129%

IDEAYA Biosciences, Inc.IDYA

$3.05M+11.8%

IncyteINCY

$23.45M+1,186%

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's change in AP?: Arcus Biosciences (RCUS) reported change in AP of -$3M in Q1 2026.
How has Arcus Biosciences's change in AP changed year-over-year?: Arcus Biosciences's change in AP decreased by 200.0% year-over-year, from $3M to -$3M.
What is the long-term trend for Arcus Biosciences's change in AP?: Over 3 years (2021 to 2025), Arcus Biosciences's change in AP has grown at a 64.2% compound annual growth rate (CAGR), from -$5.42M to $24M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.